Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies
Publication
, Conference
Prasad, VK; Chen, D-F; Reinsmoen, NL; Broadwater, G; Chao, NJ; Rizzieri, DA
Published in: Biology of Blood and Marrow Transplantation
February 2006
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2006
Volume
12
Issue
2
Start / End Page
15 / 15
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Prasad, V. K., Chen, D.-F., Reinsmoen, N. L., Broadwater, G., Chao, N. J., & Rizzieri, D. A. (2006). Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies. In Biology of Blood and Marrow Transplantation (Vol. 12, pp. 15–15). Elsevier BV. https://doi.org/10.1016/j.bbmt.2005.11.050
Prasad, V. K., D. -. F. Chen, N. L. Reinsmoen, G. Broadwater, N. J. Chao, and D. A. Rizzieri. “Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies.” In Biology of Blood and Marrow Transplantation, 12:15–15. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.050.
Prasad VK, Chen D-F, Reinsmoen NL, Broadwater G, Chao NJ, Rizzieri DA. Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 15–15.
Prasad, V. K., et al. “Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies.” Biology of Blood and Marrow Transplantation, vol. 12, no. 2, Elsevier BV, 2006, pp. 15–15. Crossref, doi:10.1016/j.bbmt.2005.11.050.
Prasad VK, Chen D-F, Reinsmoen NL, Broadwater G, Chao NJ, Rizzieri DA. Impact of donor KIR genotype and recipient HLA ligand incompatibility on relapse related mortality and acute graft versus host disease in high-risk patients undergoing haploidentical non-myeloablative peripheral blood stem cell transplants: Differences between lymphoid and myeloid malignancies. Biology of Blood and Marrow Transplantation. Elsevier BV; 2006. p. 15–15.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2006
Volume
12
Issue
2
Start / End Page
15 / 15
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences